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Abstract
Background: The need for mandatory confirmation of negative conversion in Klebsiella pneumoniae bacteremia
(KpB) has not been adequately addressed. We conducted a retrospective case–control study of adult patients with
KpB over a 5-year period in two tertiary-care hospitals to determine the risk factors for persistent bacteremia and to
reevaluate the necessity of follow-up blood culture in KpB.
Methods: Persistent KpB is defined as the finding of K. pneumoniae in more than two separate blood-culture
samples for longer than a two-day period in a single episode. The case- and control-groups were patients with
persistent and non-persistent KpB, respectively, and they were matched 1-to-3 according to age and gender.
Results: Among 1068 KpB episodes analyzed after excluding polymicrobial infection and repeated KpB, follow-up
blood cultures were performed in 862 cases (80.7%), 62 of which (7.2%) were persistent. Independent risk factors for
persistence were intra-abdominal infection, higher Charlson’s comorbidity weighted index score, prior solid organ
transplantation, and unfavorable treatment response, which was defined as positivity for at least two parameters
among fever, leukocytosis, and no decrease of C-reactive protein on the second day after initial culture. A proposed
scoring system using four variables, namely, intra-abdominal infection, nosocomial KpB, fever and lack of C-reactive
protein decrease, the last two being assessed on the second day after the initial blood culture, showed that only
4.9% of the patients with no risk factors or with only intra-abdominal infection had persistent KpB.
Conclusions: Though persistent KpB is uncommon, follow-up blood culture was performed in as many as 80% of
the cases in this study. A more careful clinical assessment is warranted to reduce the cost and patient
inconvenience involved in follow-up blood culture.
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Background
Klebsiella pneumoniae is one of the most important path-
ogens causing urinary tract infection, pneumonia, intra-
abdominal infection, and primary bacteremia. It is also the
second most common cause of community- and hospital-
acquired gram-negative bacteremia [1-3]. Mortality from
Klebsiella pneumoniae bacteremia (KpB) is about 20 to
40% [3-5], and its population-based incidence ranges from
7.1 to 9.7 per 100,000 person-years [5,6].
There is evidence that the usefulness of routine blood
cultures should be reconsidered in acute pyelonephritis
[7,8], cellulitis [9], community-acquired pneumonia
[10,11], and in isolated fever or leukocytosis [12]. Al-
though attempts have been made to reduce unnecessary
blood cultures by introducing clinical rules [12-14], clear
guidelines have yet to emerge as to when blood cultures
should be drawn. And blood cultures are liberally pre-
scribed because of the high mortality due to bacteremia,
anxiety about undertreatment, and fear of using
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inappropriate antimicrobial agents causing limited posi-
tivity of 4 to 7% [12,15,16].
Although it is widely appreciated that the requirement
for follow-up blood cultures in bacteremic patients is
questionable, they may still be prescribed too liberally,
resulting in low rates of positive outcomes. Although
routine follow-up blood culture is recommended in
Staphylococcus aureus bacteremia and in infective endo-
carditis [17], the need for mandatory confirmation of
negative conversion in KpB has not been adequately
addressed. The objective of the present study was to de-
termine the risk factors for persistent bacteremia and to
reevaluate the need for routine follow-up blood cultures
in KpB.
Methods
Study setting and patients
Data on all episodes of KpB were collected from the
electronic medical record systems between January 2007
and December 2011 at Seoul National University Hospital
(a 1600-bed tertiary-care hospital, Seoul, Korea) and
Seoul National University Bundang Hospital (a 900-bed
tertiary-care hospital, Seongnam, Korea). All adult patients
(≥ 18 years) who suffered their first KpB episodes were en-
rolled. Cases of polymicrobial infection, and repeated epi-
sodes of KpB in the same patient, were excluded.
Case- and control-patients were those with persistent
KpB and non-persistent KpB, respectively. They were
matched 1-to-3 according to age and gender using a
greedy algorithm. The data reviewed included primary
site of infection, Charlson’s co-morbidity weighted index
[18], intensive care unit (ICU) admission during the epi-
sode of KpB, severity of illness as measured by the Acute
Physiology and Chronic Health Evaluation (APACHE) II
score [19] and Pitt bacteremia score [20]; also microbio-
logic characteristics, both appropriateness of empirical
antibiotic regimen and length of time from initial blood
culture to antibiotic administration, as well as presence of
fever, leukocytosis, and the trend of C-reactive protein
(CRP) on the second day after initial blood culture. We
also assessed the nosocomial or community onset of KpB,
presentation with septic shock, presence of metastatic
infection, antibiotic or immunosuppressive therapy within
the previous year, history of solid organ transplantation,
any invasive procedure undertaken and neutropenia
within 72 hours before the onset of KpB, together with in-
hospital mortality, and length of hospital stay.
The study was approved by the institutional review
board of Seoul National University Hospital and Seoul
National University Bundang Hospital.
Definitions
The initial blood culture was defined as the first positive
blood culture for K. pneumoniae. Persistent KpB was
defined as finding of K. pneumoniae in more than one
separate blood cultures for longer than a 2-day period in
a single infection episode. When an isolate was resistant
to both cefotaxime and ceftazidime, it was suspected of
being extended-spectrum β-lactamase (ESBL)-producing
K. pneumoniae. A nosocomial infection was defined as
an infection that occurred more than 48 hours after admis-
sion to hospital [21]. Fever and leukocytosis were defined
as body temperature of ≥38°C and white blood cell count
of >10,000 /μL. Neutropenia was defined as an absolute
neutrophil count below 500/mL. Invasive procedures in-
cluded insertion of a central venous catheter, endoscopy,
endoscopic retrograde cholangiopancreatography, inser-
tion of a nasogastric tube, bronchoscopy, parenteral nutri-
tion, and insertion or manipulation of a percutaneous
transhepatic biliary drainage [22].
Antimicrobial therapy was considered inappropriate if
the isolate was not susceptible to the chosen antibiotic
in vitro. The presence of at least two of the following:
fever, leukocytosis, and lack of CRP decrease on the sec-
ond day after initial blood culture, was pre-defined as an
unfavorable treatment response before data collection.
Microbiologic analyses
BacT/ALERT FA and FN (bioMe´rieux, Durham, North
Carolina) was used for all blood cultures. Antimicrobial
susceptibility was identified with a Microscan WalkAway-
96 (Siemens Healthcare Diagnostics, Deerfield, Illinois)
and VITEK 2 (bioMe´rieux, Marcy L’etoil, France), using
the criteria of the Clinical and Laboratory Standards Insti-
tute (CLSI) guidelines. For suspected ESBL-producing
K. pneumoniae isolates, ESBL production was confirmed
by the double disk synergy test according to the CLSI per-
formance standards [17].
Statistical analyses
Conditional logistic regression was used in univariable
and multivariable analyses to manage matched data. Var-
iables with P values of < 0.10 in the univariable analysis
or of clinical importance (i.e., intra-abdominal infection)
were subjected to multivariable analysis. To evaluate the
proposed scoring system, a receiver operating characteris-
tic (ROC) analysis was carried out. P <0.05 was considered
statistically significant. PASW for Windows (version 18
software package; SPSS Inc., Chicago, IL, USA) was used
in the analyses.
Results
Rate of follow-up blood culture and incidence of
persistent KpB
Of a total of 1372 KpB episodes during the study period,
1068 were included in this study, after excluding 173
cases of polymicrobial infection and 131 cases of re-
peated KpB. Among the 1068 enrolled cases of KpB,
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follow-up blood cultures were performed in 862 cases
(80.7%), and their incidence was highest on the second
day after the initial blood culture (Additional file 1:
Figure S1). Sixty-two (7.2%) were found to be persistent
KpB, and 186 non-persistent KpB cases were matched
with the latter as described above.
Risk factors for persistent KpB
Univariable analysis of the data indicated that the factors
significantly associated with persistent KpB as opposed
to non-persistent KpB included higher Charlson’s
comorbidity weighted index score, ICU admission, noso-
comial infection, immunosuppressive therapy during the
previous year, history of solid organ transplantation, in-
vasive procedure during the previous 72 hours, fever
and lack of CRP decrease on the second day after initial
blood culture, ESBL-producing KpB, inappropriate em-
pirical antibiotic use, and in-hospital mortality (Table 1).
Multivariable analysis revealed that the independent
risk factors for persistent KpB were intra-abdominal in-
fection (adjusted odds ratio [aOR], 2.99; 95% confidence
interval [CI], 1.07-8.31; P = 0.036), higher Charlson’s
Table 1 Univariable analysis for risk factors associated with persistent Klebsiella pneumoniae bacteremia (cases)
vs. non-persistent Klebsiella pneumoniae bacteremia (controls)
Variables Cases (n = 62) Controls (n = 186) OR (95% CI) P
Age (± SD) 63.77 (± 14.58) 63.58 (± 14.34)
Male sex 45 (72.6) 135 (72.6)
Urinary tract infection 7 (11.3) 20 (10.8) 1.05 (0.43-2.58) 0.908
Intra-abdominal infection 12 (19.4) 22 (11.8) 1.82 (0.83-4.00) 0.136
Biliary tract infection 13 (21.0) 53 (28.5) 0.65 (.032-1.32) 0.236
Liver abscess 8 (12.9) 31 (16.7) 0.73 (0.31-1.72) 0.469
Pneumonia 8 (12.9) 18 (9.7) 1.36 (0.57-3.20) 0.487
Primary bacteremia 9 (14.5) 34 (18.3) 0.73 (0.31-1.72) 0.474
Central venous catheter related infection 2 (3.2) 4 (2.2) 1.50 (0.28-8.19) 0.640
Charlson’s CWI score (± SD) 6.29 (± 3.05) 5.52 (± 2.94) 1.14 (1.01-1.28) 0.037
ICU admission 18 (29.0) 30 (16.1) 2.12 (1.08-4.16) 0.029
Presentation with septic shock 22 (35.5) 53 (28.5) 1.35 (0.75-2.44) 0.316
APACHE-II score (± SD) 18.97 (± 9.28) 17.09 (± 8.16) 1.03 (0.99-1.06) 0.140
Pitt bacteremia score (± SD) 2.45 (± 2.67) 2.17 (± 2.45) 1.04 (0.94-1.16) 0.452
Nosocomial infection 34 (54.8) 55 (29.6) 2.96 (1.61-5.43) <0.001
Previous antibiotic use≤ 1 year 37 (59.7) 95 (51.1) 1.42 (0.79-2.54) 0.240
Immunosuppressive therapy ≤ 1 year 5 (8.1) 4 (2.2) 4.46 (1.05-18.95) 0.043
History of solid organ transplantation 4 (6.5) 2 (1.1) 10.18 (1.11-93.02) 0.040
Invasive procedure ≤ 72 hours before initial BC 20 (32.3) 30 (16.1) 2.56 (1.29-5.07) 0.007
Neutropenia≤ 72 hours before initial BC 11 (17.7) 31 (16.7) 1.08 (0.50-2.33) 0.843
Presence of metastatic infection 5 (8.1) 9 (4.8) 1.67 (0.56-4.97) 0.360
Inappropriate drainage 11 (17.7) 20 (10.8) 1.81 (0.80-4.07) 0.154
Fever on the 2nd day after initial BC 38 (61.3) 46 (24.7) 5.18 (2.64-10.16) <0.001
Leukocytosis on the 2nd day after initial BC 23 (37.1) 60 (32.3) 1.22 (0.68-2.19) 0.499
Lack of CRP decrease on the 2nd day after initial BC 26 (41.9) 43 (23.1) 2.38 (1.29-4.39) 0.010
Unfavorable treatment response on the 2nd day after initial BC 27 (43.5) 30 (16.1) 4.69 (2.27-9.69) <0.001
ESBL-producing Klebsiella pneumoniae bacteremia 28 (45.2) 31 (16.7) 3.99 (2.09-7.63) <0.001
Inappropriate empirical antibiotic use 22 (35.5) 24 (12.9) 4.02 (1.95-8.31) <0.001
Length of time to empirical antibiotic administration from initial BC (minute, ± SD) 182.8 (± 221.3) 228.4 (± 434.8) 1.00 (0.99-1.00) 0.430
In-hospital mortality 19 (30.6) 34 (18.3) 1.96 (1.02-3.78) 0.044
Length of hospital stay (day, ± SD) 45.1 (± 43.0) 38.6 (± 74.9) 1.00 (0.99-1.01) 0.524
Data are no. (%) of patients, unless otherwise indicated.
OR, odds ratio; CI, confidence interval; SD, standard deviation; CWI, comorbidity weighted index; ICU, intensive care unit; APACHE, acute physiology and chronic
health evaluation; BC, blood culture; CRP, C-reactive protein; ESBL, extended-spectrum β -lactamase.
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comorbidity weighted index score (aOR, 1.18 per each
point; 95% CI, 1.01-1.36; P = 0.032), history of solid
organ transplantation (aOR, 92.23; 95% CI, 1.27-6689.96;
P = 0.038), and unfavorable treatment response (aOR,
4.79; 95% CI, 1.89-12.14; P = 0.001). The concept of
unfavorable treatment response was introduced and
substituted for fever, leukocytosis, and lack of CRP de-
crease in the multivariable analysis, to avoid the
multicolinearity among those three variables. Neither
ESBL-producing KpB nor inappropriate empirical anti-
biotic use was found to be an independent risk factor
(Table 2).
Percentage of persistent KpB according to clinical score
To estimate the likelihood of persistent KpB, a scoring
system was introduced, based on the presence or ab-
sence of four risk factors viz. intra-abdominal infection,
nosocomial KpB, fever and lack of CRP decrease, the last
two being assessed on the second day after initial blood
culture. According to their odds ratio in a conditional
logistic regression with these four risk factors, the
weighted scores given for the risk factors were 1, 2, 3,
and 2, respectively (Table 3).
The frequency of persistent KpB exceeded 50% when
the score was greater than five; conversely, it was only
4.9% when the score was zero to one with no risk fac-
tors, or with intra-abdominal infection as the only risk
factor (Figure 1). This indicates that persistent KpB is
likely to be rarer among patients with fewer risk factors.
A ROC analysis showed that the area under the curve
was 0.78 (P <0.0001) and the best cut-off was 2 (sensitiv-
ity, 0.81; specificity, 0.64, Additional file 2: Figure S2).
Discussion
K. pneumoniae is one of the most important pathogens
causing nosocomial and community-acquired infections,
and clinicians sometimes encounter persistent KpB in
clinical practice. Despite the fact that the CLSI guidelines
do not recommend routine follow-up blood cultures
except in cases of Staphylococcus aureus bacteremia and
infective endocarditis [17], our understanding of the oc-
currence of persistent KpB and the frequency of follow-up
blood cultures is far from complete. The present study
showed that, although follow-up blood cultures were
performed in 80.7% of the cases, only 7.2% were found to
be persistent KpB. Furthermore, more than two consecu-
tive blood cultures were performed in 53.2% of the pa-
tients with non-persistent KpB in the present study (Data
not shown). These results imply that most of these follow-
up blood cultures would have been unwarranted. Studies
have shown that only 4 to 7% of blood cultures are posi-
tive owing to its liberal prescription [12,15,16], and our
data with follow-up blood cultures also point to a similar
situation. Our multivariable analysis revealed that unfavor-
able treatment response was an independent risk factor
for persistent KpB, along with intra-abdominal infection,
high Charlson’s comorbidity weighted index score, and
prior solid organ transplantation. All this suggests that,
when treating suspected KpB patients, the clinical findings
should be considered carefully before opting for follow-up
blood culture, to reduce indiscriminate prescription and
the ensuing cost and patient inconvenience.
Severe underlying disease and prior organ transplant-
ation are established risk factors for KpB [4,5,23,24], as
they were for persistent KpB in this study. An intra-
abdominal origin of KpB is a known risk factor for mor-
tality [4,5], and it was also significantly associated with
persistent KpB in our analysis. Although the KpB of re-
spiratory tract origin has been documented to be a risk
factor for mortality [4,5,23], it was not significantly asso-
ciated with persistent KpB in this study. It would be in-
teresting to find their association further by taking many
factors into account, including the limitations of this
study as explained below.
Table 2 Independent risk factors for persistent Klebsiella pneumoniae bacteremia
Variables Adjusted OR (95% CI) P
Intra-abdominal infection 2.99 (1.07-8.31) 0.036
Charlson’s CWI score (± SD) 1.18 (1.01-1.36) 0.032
ICU admission 1.98 (0.80-4.87) 0.139
Nosocomial infection 2.05 (0.81-5.21) 0.130
Immunosuppressive therapy ≤ 1 year 0.36 (0.02-8.90) 0.533
History of solid organ transplantation 92.23 (1.27-6689.96) 0.038
Invasive procedure≤ 72 hours before initial BC 0.77 (0.27-2.19) 0.618
Unfavorable treatment response on the 2nd day after initial BC 4.79 (1.89-12.14) 0.001
ESBL-producing Klebsiella pneumoniae bacteremia 1.72 (0.63-4.69) 0.293
Inappropriate empirical antibiotic use 2.76 (0.93-8.23) 0.068
OR, odds ratio; CI, confidence interval; SD, standard deviation; CWI, comorbidity weighted index; ICU, intensive care unit; BC, blood culture; ESBL,
extended-spectrum β -lactamase.
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According to Kang et al. [25,26], ESBL-producing or-
ganism and inappropriate empirical antibiotic are not
risk factors for increased mortality in bloodstream infec-
tions due to K. pneumoniae. We also found that produc-
tion of ESBL was not an independent risk factor for
persistent KpB, which indicates that follow-up blood cul-
tures are not routinely needed in cases of ESBL-
producing KpB. However, inappropriate empirical anti-
biotic regimen may call for further evaluation because of
its borderline P value.
Various definitions of persistent bacteremia have been
used in Staphylococcus aureus bacteremia [27-29]. Our
definition of persistent bacteremia was not as strict as
others because both the failure of appropriate antimicro-
bial therapy and prolonged periods of bacteremia were
not essential elements of our consideration. If a stricter
definition had been used, the incidence of persistent
KpB would have been further reduced, which supports
our suggestion that more care should be taken before
opting for follow-up blood culture.
Our scoring system, which has fair discriminative abil-
ity, could be used as a guide for whether a follow-up
blood culture is needed, since there was a positive rela-
tionship between clinical score and percent persistent
KpB (Figure 1): the percentage of persistent KpB
declined sharply as the score decreased, and less than
5% of the patients with zero or one point had persistent
bacteremia. On the other hand, follow-up blood culture
could be justified in patients with more than five points
because more than a half of those would be expected to
suffer from persistent bacteremia. According to our data,
if follow-up blood cultures were only carried out in pa-
tients with scores exceeding 2 points, more than 50% of
follow-up blood cultures could be avoided (Figure 1).
There are some limitations to this study. There is a
possibility of bias because it was a retrospective study
with a limited sample size. Although our scoring system
appeared to be useful, as discussed above, it should be
further assessed on a larger sample. We were not able to
evaluate the possible impact of age and gender on per-
sistent KpB by matching for these factors because of the
design of this study. Also, there may have been selection
bias in the 19.3% of patients without follow-up blood
culture, one third of whom died by the 2nd day after
blood culture (data not shown).
Persistent KpB showed significantly worse outcomes,
such as in-hospital mortality (P = 0.044) and ICU admis-
sion during the KpB episode (P = 0.029) in univariable
analyses (Table 1). However, we did not perform multi-
variable analysis for mortality-related factors, mainly
Table 3 Odds ratios and adjusted weighted scores for the four variables used in the scoring system
Variables OR Log (OR) Adjusted weighted score
Intra-abdominal infection 1.87 0.63 1
Nosocomial infection 3.24 1.18 2
Fever on the 2nd day after initial blood culture 8.30 2.12 3
Lack of CRP decrease on the 2nd day after initial blood culture 3.10 1.13 2
OR, odds ratio; CRP, C-reactive protein.
Figure 1 Percentage of persistent Klebsiella pneumoniae bacteremia and number of cases according to clinical score. There was a
positive relationship between clinical score and percent persistent KpB.
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because the study design was focused on persistence of
bacteremia, and also the matching was carried out in
that context.
Finally, this study was undertaken in university-
affiliated tertiary-care hospitals where a large proportion
of the patients might have severe underlying diseases in-
cluding malignancy. However, 64.1% and 25.0% of our
cases involved community-onset and community-
acquired KpB, respectively (data not shown). The rate
of persistent KpB would be expected to be much lower in
a community-based hospital since a high Charlson’s
comorbidity weighed index score is an independent risk
factor for persistent KpB and the comorbidities in patients
in community-based hospitals are likely to be less severe.
Conclusions
In conclusion, unfavorable treatment response on the
second day after initial blood culture, intra-abdominal
infection, high Charlson’s comorbidity weighted index
score, and prior solid organ transplantation are inde-
pendent risk factors for persistent KpB. Since patients
with persistent KpB were rare, especially among individ-
uals with few risk factors, routine follow-up blood culture
may not be justified. More careful clinical assessment be-
fore deciding on follow-up blood culture would reduce
costs and inconvenience to patients.
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